| Previous Close | 0.3600 |
| Open | 0.3550 |
| Bid | 0.3500 x 0 |
| Ask | 0.3700 x 0 |
| Day's Range | 0.3500 - 0.3600 |
| 52 Week Range | 0.1000 - 0.6300 |
| Volume | 25,610 |
| Avg. Volume | 21,808 |
| Market Cap | 30.658M |
| Beta (5Y Monthly) | 3.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0030 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Philips showcases integrated radiation oncology solutions to streamline diagnosis and treatment at ASTRO 2020
IntelliSpace Radiation Oncology IntelliSpace Radiation Oncology clinician discussion October 22, 2020Radiation Oncology Orchestrator (IntelliSpace Radiation Oncology) and Practice Management [1] can reduce the time from patient referral to the start of treatment by up to halfAmsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest advances in radiation oncology at the American Society for Radiation Oncology (ASTRO) annual meeting (October 24-28). During the virtual event, Philips will showcase its comprehensive portfolio of integrated radiation oncology systems and AI‐powered software that helps radiation oncologists manage complexity and boost efficiencies to accelerate the time from patient referral to treatment.As diagnostic and treatment workloads expand in both volume and complexity, radiation therapy departments are under mounting pressure to provide accurate treatment, while minimizing wait times for patients. Today, the radiation oncology planning process can be labor-intensive, with frequent handovers, long wait times and lags in data transfers between systems. By optimizing workflows, standardizing processes, and providing easy access to relevant patient information, Philips supports care teams by integrating clinical workflows, reducing wait times and increasing confidence in decision-making.“Healthcare providers are rethinking the way they organize care in order to support a streamlined, end-to-end exchange of data, which can help them achieve a faster workflow, address capability gaps and reduce costs,” said Ardie Ermers, Vice President and General Manager Radiation Oncology at Philips. “With our broad portfolio of oncology technologies and solutions, Philips is in a unique position to help providers across the end-to-end patient pathway, optimizing workflows and generating insights from integrated diagnostics, aiming for clear care pathways and predictable outcomes for every patient.”An integrated solution supported by consultancy services IntelliSpace Radiation Oncology [1] enables radiotherapy departments to achieve operational excellence and accelerate the time from referral of the patient to the start of their treatment. By integrating the analytics and on-site change management features of Philips’ Practice Management solution [1], radiotherapy departments can identify and act on data-driven insights to address performance gaps, monitor progress and drive sustainable change.The South West Wales Cancer Centre (SWWCC) in the UK is among the first partner sites that have deployed the solution. “This new intelligent patient management orchestrator helps our patients by improving their experience by decreasing their time to treatment and it will help us as clinicians to consistently treat every patient to the highest quality levels,” said Dr. Russell Banner, Clinical Oncologist, and Radiotherapy Lead at SWWCC. “Our 14-step breast pathway had a referral-to-first treatment interval of 32 days initially. With full implementation of IntelliSpace Radiation Oncology and the Practice Management consultants, we think it is achievable to bring this down to just 14 days.”Advanced Imaging and treatment planning tools At ASTRO and beyond on its virtual radiation oncology experience website, Philips will present its dedicated radiation oncology line-up, including the Big Bore RT scanning and simulation platform (Big Bore RT) and the comprehensive MR simulation platform (Ingenia MR-RT). Philips continues to advance its leading MR-only radiotherapy portfolio, receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AI-based MRCAT Brain application earlier this year. MRCAT reduces the organization and coordination of scans involved in MR-CT registration, saving the patient from undergoing another imaging procedure. MRCAT scans are now accelerated by Compressed Sense, a technology that speeds up scans by up to 50% [2], further helping to improve patient comfort.Advanced imaging capabilities tailored for MR in Radiotherapy from Philips being highlighted for ASTRO include functional imaging using DWI XD TSE with reduced distortion [3], metal artifact reduction with OMAR XD, and motion management with 3D Vane XD, which supports imaging of the abdomen without the need for the patient to hold their breath.As the company further consolidates its radiation oncology IT platform, Philips is also showcasing its next generation of personalized IMRT and VMAT Therapy Planning System (Pinnacle Evolution) which improves the quality, consistency and efficiency of the therapy planning process.End-to-end oncology care With its broad portfolio of oncology-related technologies and solutions that span the end-to-end patient care-path, Philips is in a unique position to help oncology care providers to connect the disparate pathway processes and workflows to improve the efficiency, robustness and quality of oncology care. More information on Philips’ oncology portfolio is available here.[1] Not available for sale in all markets. [2] Compared to Philips scans without Compressed SENSE. [3] Compared to EPI diffusion DWI.For further information, please contact:Kathy O’Reilly Philips Global Press Office Tel.: +1 978-221-8919 E-mail: kathy.oreilly@philips.com Twitter: @kathyoreillyMark Groves Philips Global Press Office Tel: +31 631 639 916 Email: mark.groves@philips.com Twitter: mark_grovesAbout Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments * IntelliSpace Radiation Oncology * IntelliSpace Radiation Oncology clinician discussion
- GlobeNewswire
SimonMed Imaging partners with Philips to deploy new diagnostic imaging technology to advance radiology workflow performance
Philips’ Ingenia Elition MR Philips’ AI Enhanced MR Technology October 21, 2020SimonMed will introduce Philips’ state-of-the-art 3T MR services to help improve patient care while increasing patient and staff satisfaction at a lower cost Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that SimonMed Imaging, one of the largest outpatient imaging providers in the U.S., will bring the most advanced 3T MRI Philips technology to its centers of excellence across the U.S. The first MR systems, placed in California, Arizona, Illinois and Colorado, will feature software and services to enhance diagnoses ranging from brain injuries, liver and cardiac disease, to orthopedic injuries. Philips and SimonMed are also collaborating to further enhance the patient experience and speed in diagnostic imaging.Advanced MR technology enhances patient experience and workflow efficiency Faced with increased financial pressures and demands due in large part to COVID-19, imaging providers are dealing with a growing and aging co-morbid patient population who need and deserve the most advanced care. Driving day-to-day operations, while planning for long-term strategies, are necessary to continue to deliver consistent, high-quality care. Together with their customers, Philips takes a systems view approach to imaging that delivers an end-to-end solution, helping provide consistently high-quality imaging services to referring physicians so they can deliver more definitive diagnoses, clear care pathways and more predictable outcomes for patients.Patients are at the heart of the Philips MR System Ingenia Elition 3.0T, providing an experience to SimonMed Imaging that enhances comfort while reducing the likelihood of rescans [1]. With up to 80% acoustic noise reduction, voice guidance, and comfortable table positioning, patients are made to feel at ease, resulting in smoother, faster exams [2]. With revolutionary sensing technology, Ingenia Elition delivers innovative patient comfort and enhanced workflow capabilities for faster and more patient-friendly exams. This new paradigm in productivity applies to all anatomies and anatomical contrasts. “This collaboration with Philips focuses on going beyond routine 3T MRI imaging to deploy the most advanced technology, often only available to an academic center, in accessible and affordable outpatient practice to greatly enhance diagnoses from early post-traumatic brain injuries to the most subtle orthopedic injuries,” said Dr. John Simon, CEO, SimonMed Imaging. “Patients will literally have access to the entire spectrum of the newest techniques and enhanced diagnoses. Together with Philips, we continue our efforts to see beyond current technology as the rate of change is tremendous, and bring these powerful advancements to help benefit both providers and patients.”“Now more than ever, we continue our commitment to advanced technology and efficient workflows to drive enhanced integration, virtualization and digitalization to deliver precision diagnoses required during these most challenging times. Providing our customers with a clear path to precision diagnosis and treatment to help achieve better outcomes at a lower cost of care is at the center of all we do,” said Kees Wesdorp, Chief Business Leader, Precision Diagnosis at Philips. “Our advanced MR technology, combined with our advanced integrated radiology workflows, is the latest innovation to further demonstrate our commitment in driving technology to help our forward-thinking customers like SimonMed advance care for their patients.”Philips advanced MR systems at SimonMed Imaging Philips MR systems, including the Ingenia Elition, offer cutting-edge MR imaging techniques, while setting new directions for clinical research in 3.0T imaging based on gradient and RF designs. The system delivers superb image quality and performs MRI exams up to 50% faster [3]. Having access to new diagnostic techniques, such as mapping the white matter to evaluate brain trauma, supports confident diagnosis even in the most challenging clinical indications.Philips Live at RSNA 2020 Philips brings together smart diagnostic systems and optimized workflows with integrated diagnostic insights – including imaging, monitoring, laboratory, genomics and longitudinal data – to enable a clear care pathway with predictable outcomes for patients. At the RSNA 2020 virtual event, Philips will showcase an end-to-end systems view of imaging to provide consistently high-quality imaging services to deliver more definitive diagnoses. Visit Philips Live at RSNA 2020 for more information on Philips integrated workflow solutions to connect data, technology and people across the diagnostic enterprise, helping to redefine radiology workflow efficiencies. [1] Compared to the average number of rescans reported on the other five on-site Philips MR scanners without Ambient Experience and In-bore Connect. Results from case studies are not predictive of results in other cases. Results in other cases may vary. [2] Compared to scanning without ComforTone. [3] Compared to Philips scans without Compressed SENSE.For further information, please contact:Kathy O’Reilly Philips Global Press Office Tel.: +1 978-221-8919 E-mail : kathy.oreilly@philips.com Twitter: @kathyoreillyAbout Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter. Attachments * Philips’ Ingenia Elition MR * Philips’ AI Enhanced MR Technology
- GlobeNewswire
Philips and Marienhospital Stuttgart sign 10-year strategic partnership to improve patient care and efficiency
Marienhospital Stuttgart October 21, 2020 * Long-term agreement guarantees access to state-of-the-art solutions, controls costs, and ensures security of future investment * Fully-integrated approach deploying Philips’ digital healthcare solutions across multiple departments to enhance the experience of Marienhospital Stuttgart’s patient and staffAmsterdam, the Netherlands and Stuttgart, Germany – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Marienhospital Stuttgart (Germany) today signed a 10-year strategic partnership agreement to expand world-class medicine at the hospital and provide integrated patient care. The project will include renewal and ongoing development of the hospital’s diagnostic imaging equipment and associated IT systems, digitization of its pathology department, and enhancement of the hospital’s emergency medicine capabilities.Rather than treating each of these improvement areas as a separate exercise, Philips and Marienhospital Stuttgart will integrate them into connected patient care and optimized efficiency solutions. This will involve analysis of the hospital’s current treatment structures and pathways to enhance the overall quality of the hospital’s structures, processes and results, while also identifying potential cost savings. By jointly developing needs-based technology solutions, Marienhospital Stuttgart will be able to better plan its costs and ensure investment security in all areas.“Due to the long-term nature of our partnership with Philips, our hospital will not only actively participate in future technological advances in healthcare, but also become a leader,” said Markus Mord, Managing Director of Marienhospital Stuttgart. “It will enable us to offer our patients diagnostic and therapeutic procedures that consistently meet the latest standards. We live medicine and always focus on the well-being of our patients.”“As a solution provider, we specialize in partnering with our customers to provide integrated care concepts that enhance treatment pathways for their patients,” said Peter Vullinghs, Managing Director Philips DACH. “With new, highly innovative approaches, we will help to enhance the quality of medical care for the benefit of the patient across the board. We look forward to many years of mutual cooperation with Marienhospital Stuttgart."Reliable diagnosis through digital pathology A core element of the collaboration is redesign of the hospital’s pathology department workflow, replacing conventional microscopes and glass slides with Philips’ high-performance digital pathology slide scanners and computer workstations. This will allow slide images to be managed, displayed, analyzed and discussed with clinical colleagues – for example, during tumor boards for the diagnosis and treatment of cancers. The ability to share slide images will also enable virtual consultations with experts from other hospitals. Competence networks like this combine the experience of doctors working in the clinic with the knowledge of their research colleagues, speeding up right-first-time diagnosis and the initiation of therapy.Radiology for current and future needs Reflecting the holistic nature of the partnership model, Philips will also help to analyze and redefine Marienhospital Stuttgart’s radiology procedures, processes and IT systems, as well as coordinating equipment renewal and expansion. Under the terms of the agreement, Philips will be responsible for the procurement, installation, maintenance (including updates and upgrades) and servicing of all large radiology equipment, with an obligation to ensure the availability of equipment in line with the strategic orientation of the hospital.Emergency medicine for enhanced patient and staff experiences As the first point of contact for patients with acute health problems, Marienhospital Stuttgart’s Clinic for Emergency Medicine plays a central role in its care concept. A working group from Philips and the hospital has already examined the clinic’s current status and development potential against the background of a holistic care approach, including assessment of patient safety, processes, procedures, technical equipment and staff working conditions. The knowledge gained from this will be incorporated into the clinic’s future structural planning and implementation.For further information, please contact:Mark Groves Philips Group Press Office Tel: +31 631 639 916 Email: mark.groves@philips.com Twitter: mark_grovesAnnette Halstrick PR Manager Philips DACH Tel: +49 152 2280 0529 Email: annette.halstrick@philips.comAbout Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.About Marienhospital Stuttgart The Marienhospital Stuttgart was founded in 1890. It is still owned by the Sisters of Mercy of Saint Vincent de Paul in Untermarchtal. From a small hospital with 15 nuns and 90 beds, it has developed into a large hospital and today has 761 beds and well over 2,000 employees. Marienhospital Stuttgart regularly receives recognition from independent institutions such as health insurance companies, magazines and associations; among other things as one of the best hospitals and one of the best employers in Germany. From the beginning, two characteristics have been one of the cornerstones of the hospital: human attention to the patient and medicine that was technically always up-to-date or ahead of its time. As early as 1908, the hospital was one of the first hospitals to acquire an X-ray machine and in the 130 years of its existence it has always been one of the most technically advanced hospitals in Germany. More about Marienhospital Stuttgart: https://www.marienhospital-stuttgart.de Attachment * Marienhospital Stuttgart
